B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.
about
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma.Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinomaActivation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma
P2860
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@en
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@nl
type
label
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@en
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@nl
prefLabel
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@en
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@nl
P2093
P2860
P1476
B-Cell Lymphoma Patient-Derive ...... form for Personalized Therapy.
@en
P2093
Bingliang Fang
David Santos
Jacqueline Wang
Jeremy Segal
Krystle Nomie
P2860
P304
P356
10.1158/1078-0432.CCR-16-2703
P407
P50
P577
2017-03-27T00:00:00Z